國立高雄大學圖資館 |

Language: English

Back

Biomarkers in inflammatory bowel dis...

De Cruz, Peter.

Biomarkers in inflammatory bowel diseases

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biomarkers in inflammatory bowel diseasesedited by Nik Sheng Ding, Peter De Cruz.
other author:	Sheng Ding, Nik.
Published:	Cham :Springer International Publishing :2019.
Description:	xvii, 365 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Inflammatory bowel diseasesMolecular diagnosis.
Online resource:	https://doi.org/10.1007/978-3-030-11446-6
ISBN:	9783030114466$q(electronic bk.)

Biomarkers in inflammatory bowel diseases
Biomarkers in inflammatory bowel diseases[electronic resource] /edited by Nik Sheng Ding, Peter De Cruz. - Cham :Springer International Publishing :2019. - xvii, 365 p. :ill. (some col.), digital ;24 cm.

Part I: Introduction -- nflammatory bowel disease - more than meets the eye - Clinical risk factors - lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers - Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn's disease -- Luminal Crohn's disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn's disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.

This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.

ISBN: 9783030114466$q(electronic bk.)

Standard No.: 10.1007/978-3-030-11446-6doiSubjects--Topical Terms:

841995
Inflammatory bowel diseases
--Molecular diagnosis.

LC Class. No.: RC862.I53 / B566 2019

Dewey Class. No.: 616.344

Biomarkers in inflammatory bowel diseases
LDR:03250nmm a2200325 a 4500 001 559102
003 DE-He213
005 20191106153219.0
006 m d
007 cr nn 008maaau
008 191219s2019 gw s 0 eng d
020 $a 9783030114466$q(electronic bk.)
020 $a 9783030114459$q(paper)
024 7 $a 10.1007/978-3-030-11446-6 $2 doi
035 $a 978-3-030-11446-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC862.I53 $b B566 2019
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.344 $2 23
090 $a RC862.I53 $b B615 2019
245 0 0 $a Biomarkers in inflammatory bowel diseases $h [electronic resource] / $c edited by Nik Sheng Ding, Peter De Cruz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xvii, 365 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Part I: Introduction -- nflammatory bowel disease - more than meets the eye - Clinical risk factors - lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers - Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn's disease -- Luminal Crohn's disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn's disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.
520 $a This book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
650 0 $a Inflammatory bowel diseases $x Molecular diagnosis. $3 841995
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Gastroenterology. $3 274091
650 2 4 $a Microbial Genetics and Genomics. $3 273651
650 2 4 $a Proteomics. $3 220403
700 1 $a Sheng Ding, Nik. $3 841994
700 1 $a De Cruz, Peter. $3 226759
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-11446-6
950 $a Medicine (Springer-11650)